Related Experiment Videos
Experimental autoimmune encephalomyelitis in IL-4-deficient mice
R Liblau1, L Steinman, S Brocke
1Department of Microbiology and Immunology, Stanford University School of Medicine, CA 94305, USA.
International Immunology
|May 1, 1997
Summary
Interleukin-4 (IL-4) is not essential for the natural recovery or relapse prevention in experimental autoimmune encephalomyelitis (EAE). Compensatory immune mechanisms likely manage central nervous system inflammation in IL-4-deficient mice.
Area of Science:
- Immunology
- Neuroscience
- Autoimmunity
Background:
- Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease.
- Autoreactive Th1 CD4+ T cells drive EAE lesions, while Th2 CD4+ T cells can suppress it.
- The specific role of IL-4 and Th2 cells in EAE remission and relapse prevention remains unclear.
Purpose of the Study:
- To investigate the necessity of IL-4 for spontaneous remission and relapse prevention in EAE.
- To understand the compensatory immunoregulatory mechanisms in the absence of IL-4.
Main Methods:
- Utilized IL-4-deficient (IL-4-/-) mice compared to wild-type (IL-4+/+) and heterozygous (IL-4+/-) controls on a PL/J background.
- Actively induced EAE in these mouse models.
- Monitored and compared clinical EAE course, including frequency, severity, duration, and relapse rates.
Main Results:
- No significant differences were observed in EAE frequency, severity, duration, or relapse rates among IL-4+/+, IL-4+/-, and IL-4-/- mice.
- IL-4 is not required for the spontaneous remission of EAE.
- IL-4 is not necessary for preventing relapses in EAE.
Conclusions:
- IL-4 is not essential for spontaneous remission or relapse prevention in experimental autoimmune encephalomyelitis.
- Compensatory immunoregulatory mechanisms effectively control central nervous system inflammation even in the absence of IL-4.